Doxorubicin plus evofosfamide versus doxorubicin alone in locally advanced, unresectable or metastatic soft-tissue sarcoma (TH CR-406/SARC021): an international, multicentre, open-label, randomised phase 3 trial (Q33442988)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Doxorubicin plus evofosfamide versus doxorubicin alone in locally advanced, unresectable or metastatic soft-tissue sarcoma (TH CR-406/SARC021): an international, multicentre, open-label, randomised phase 3 trial |
scientific article |
Statements
1 reference
Doxorubicin plus evofosfamide versus doxorubicin alone in locally advanced, unresectable or metastatic soft-tissue sarcoma (TH CR-406/SARC021): an international, multicentre, open-label, randomised phase 3 trial (English)
1 reference
Patrick Schöffski
1 reference
Peter Hohenberger
1 reference
William D Tap
1 reference
Zsuzsanna Papai
1 reference
Brian A Van Tine
1 reference
Steven Attia
1 reference
Kristen N Ganjoo
1 reference
Robin L Jones
1 reference
Scott Schuetze
1 reference
Sant P Chawla
1 reference
Richard F Riedel
1 reference
Anders Krarup-Hansen
1 reference
Maud Toulmonde
1 reference
Giovanni Grignani
1 reference
Lee D Cranmer
1 reference
Scott Okuno
1 reference
Mark Agulnik
1 reference
William Read
1 reference
Christopher W Ryan
1 reference
Thierry Alcindor
1 reference
Xavier F Garcia Del Muro
1 reference
G Thomas Budd
1 reference
Hussein Tawbi
1 reference
Tillman Pearce
1 reference
Stew Kroll
1 reference
Denise K Reinke
1 reference
23 June 2017
1 reference
1 reference
Identifiers
1 reference
1 reference